{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:34:33Z","timestamp":1792668873011,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.hoc.2021.07.010","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T10:26:22Z","timestamp":1628591182000},"page":"1181-1196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Rare Coagulation Factor Deficiencies (Factors VII, X, V, and II)"],"prefix":"10.1016","volume":"35","author":[{"given":"Glaivy","family":"Batsuli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kouides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.hoc.2021.07.010_bib1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1182\/asheducation-2016.1.663","article-title":"Treatment of rare factor deficiencies in 2016","volume":"2016","author":"Peyvandi","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"6472","key":"10.1016\/j.hoc.2021.07.010_bib2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0140-6736(47)90370-X","article-title":"Congenital hypoprothrombinaemia and pseudo-hypoprothrombinaemia","volume":"2","author":"Quick","year":"1947","journal-title":"Lancet"},{"issue":"7222","key":"10.1016\/j.hoc.2021.07.010_bib3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0140-6736(62)91073-5","article-title":"Hereditary hypoprothrombinaemias","volume":"1","author":"Quick","year":"1962","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.hoc.2021.07.010_bib4","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1365-2516.2008.01832.x","article-title":"Abnormalities of prothrombin: a review of the pathophysiology, diagnosis, and treatment","volume":"14","author":"Meeks","year":"2008","journal-title":"Haemophilia"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2021.07.010_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2006-939550","article-title":"An overview of the structure and function of thrombin","volume":"32","author":"Davie","year":"2006","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"10.1016\/j.hoc.2021.07.010_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11239-017-1488-y","article-title":"New clotting disorders that cast new light on blood coagulation and may play a role in clinical practice","volume":"44","author":"Girolami","year":"2017","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"2","key":"10.1016\/j.hoc.2021.07.010_bib7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.1538-7836.2003.00043.x","article-title":"The discovery of factor V: a tricky clotting factor","volume":"1","author":"Stormorken","year":"2003","journal-title":"J\u00a0Thromb Haemost"},{"issue":"2","key":"10.1016\/j.hoc.2021.07.010_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.moh.0000155016.30296.90","article-title":"Coagulation factor V: a plethora of anticoagulant molecules","volume":"12","author":"Kalafatis","year":"2005","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"10.1016\/j.hoc.2021.07.010_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V76.1.1.1","article-title":"Surface-dependent reactions of the vitamin K-dependent enzyme complexes","volume":"76","author":"Mann","year":"1990","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.hoc.2021.07.010_bib10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1055\/s-0039-1687906","article-title":"A\u00a0Comprehensive Overview of Coagulation Factor V and Congenital Factor V Deficiency","volume":"45","author":"Tabibian","year":"2019","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.010_bib11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/cvr\/cvt343","article-title":"Pleiotropic effects of factor Xa and thrombin: what to expect from novel anticoagulants","volume":"101","author":"Spronk","year":"2014","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.hoc.2021.07.010_bib12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1055\/s-0034-1544000","article-title":"Complex history of the discovery and characterization of congenital factor X deficiency","volume":"41","author":"Girolami","year":"2015","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"10.1016\/j.hoc.2021.07.010_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3181\/00379727-90-21927","article-title":"Clotting factor X; physiologic and physico-chemical properties","volume":"90","author":"Duckert","year":"1955","journal-title":"Proc Soc Exp Biol Med Soc Exp Biol Med (New York, NY)"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.010_bib14","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1365-2141.1956.tb06703.x","article-title":"A\u00a0new coagulation defect","volume":"2","author":"Telfer","year":"1956","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.010_bib15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1172\/JCI103446","article-title":"Stuart clotting defect. I. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called stable factor (SPCA, proconvertin, factor VII) deficiency","volume":"36","author":"Hougie","year":"1957","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.hoc.2021.07.010_bib16","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1160\/TH06-01-0060","article-title":"Polymorphisms of the protein Z-dependent protease inhibitor (ZPI) gene and the risk of venous thromboembolism","volume":"95","author":"Razzari","year":"2006","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.hoc.2021.07.010_bib17","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1182\/blood-2004-02-0595","article-title":"Recessively inherited coagulation disorders","volume":"104","author":"Mannucci","year":"2004","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.hoc.2021.07.010_bib18","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1182\/blood-2013-05-505511","article-title":"Genetic sequence analysis of inherited bleeding diseases","volume":"122","author":"Peyvandi","year":"2013","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.hoc.2021.07.010_bib19","doi-asserted-by":"crossref","first-page":"7597","DOI":"10.1073\/pnas.95.13.7597","article-title":"Prothrombin deficiency results in embryonic and neonatal lethality in mice","volume":"95","author":"Sun","year":"1998","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"6","key":"10.1016\/j.hoc.2021.07.010_bib20","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1055\/s-0037-1613344","article-title":"Rescue of prothrombin-deficiency by transgene expression in mice","volume":"88","author":"Sun","year":"2002","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.010_bib21","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1046\/j.1365-2516.2002.00633.x","article-title":"Rare coagulation deficiencies","volume":"8","author":"Peyvandi","year":"2002","journal-title":"Haemophilia"},{"issue":"6657","key":"10.1016\/j.hoc.2021.07.010_bib22","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/36862","article-title":"Mice lacking factor VII develop normally but suffer fatal perinatal bleeding","volume":"390","author":"Rosen","year":"1997","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.hoc.2021.07.010_bib23","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1111\/hae.13065","article-title":"Factor VII and factor X deficiency in a child with a chromosome 13q duplication and deletion","volume":"27","author":"Hutchins","year":"2021","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.hoc.2021.07.010_bib24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/MBC.0000000000000787","article-title":"Genotype analysis and identification of novel mutations in a multicentre cohort of patients with hereditary factor X deficiency","volume":"30","author":"Mitchell","year":"2019","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"10.1016\/j.hoc.2021.07.010_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1055\/s-0037-1613783","article-title":"Blood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice","volume":"83","author":"Dewerchin","year":"2000","journal-title":"Thromb Haemost"},{"issue":"13","key":"10.1016\/j.hoc.2021.07.010_bib26","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1182\/blood-2014-08-532820","article-title":"Rare bleeding disorders: diagnosis and treatment","volume":"125","author":"Palla","year":"2015","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2021.07.010_bib27","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1055\/s-0033-1348948","article-title":"Congenital prothrombin deficiency: an update","volume":"39","author":"Lancellotti","year":"2013","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"10.1016\/j.hoc.2021.07.010_bib28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1538-7836.2003.t01-1-00553.x","article-title":"Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias","volume":"2","author":"Acharya","year":"2004","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"10.1016\/j.hoc.2021.07.010_bib29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood-2018-06-820738","article-title":"Treatment of rare factor deficiencies other than hemophilia","volume":"133","author":"Menegatti","year":"2019","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.hoc.2021.07.010_bib30","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1542\/peds.2012-3662","article-title":"Rare bleeding disorders in children: identification and primary care management","volume":"132","author":"Acharya","year":"2013","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.hoc.2021.07.010_bib31","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1111\/j.1538-7836.2012.04844.x","article-title":"Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity","volume":"10","author":"Peyvandi","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"10.1016\/j.hoc.2021.07.010_bib32","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/hae.12669","article-title":"Lupus anticoagulant acquired hypoprothrombinemia syndrome in childhood: two distinct patterns and review of the literature","volume":"21","author":"Sarker","year":"2015","journal-title":"Haemophilia"},{"issue":"5","key":"10.1016\/j.hoc.2021.07.010_bib33","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/bjh.17308","article-title":"Acquired factor V inhibitor: a nation-wide study of 38 patients","volume":"192","author":"Goulenok","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2021.07.010_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2018.01.045","article-title":"Acquired factor V deficiency in a patient with myeloma and amyloidosis","volume":"164","author":"Quek","year":"2018","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.hoc.2021.07.010_bib35","first-page":"63","article-title":"Isolated acquired factor VII deficiency: review of the literature","volume":"71","author":"Mulliez","year":"2016","journal-title":"Acta clinica Belgica"},{"issue":"8","key":"10.1016\/j.hoc.2021.07.010_bib36","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1177\/1076029615599440","article-title":"Acquired Isolated FVII Deficiency: An Underestimated and Potentially Important Laboratory Finding","volume":"22","author":"Girolami","year":"2016","journal-title":"Clin Appl Thromb Hemost"},{"issue":"5","key":"10.1016\/j.hoc.2021.07.010_bib37","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1365-2516.2012.02773.x","article-title":"Acquired, non-amyloid related factor X deficiency: review of the literature","volume":"18","author":"Lee","year":"2012","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.010_bib38","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bjh.13058","article-title":"Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors' Organization guideline on behalf of the British Committee for Standards in Haematology","volume":"167","author":"Mumford","year":"2014","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.hoc.2021.07.010_bib39","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1538-7836.2012.04653.x","article-title":"Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders","volume":"10","author":"Peyvandi","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"10.1016\/j.hoc.2021.07.010_bib40","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1365-2516.2009.02048.x","article-title":"Factor 5 mutation profile in German patients with homozygous and heterozygous factor V deficiency","volume":"15","author":"Delev","year":"2009","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.hoc.2021.07.010_bib41","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2516.2008.01910.x","article-title":"Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene","volume":"15","author":"Herrmann","year":"2009","journal-title":"Haemophilia"},{"issue":"7","key":"10.1016\/j.hoc.2021.07.010_bib42","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/pbc.25966","article-title":"Intracranial Hemorrhage as the First Manifestation of Severe Congenital Factor X Deficiency in a 20-Month-Old Male: Case Report and Review of the Literature","volume":"63","author":"Diesch","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.hoc.2021.07.010_bib43","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/j.1365-2516.2009.02072.x","article-title":"Gynaecological and obstetrical problems in women with different bleeding disorders","volume":"15","author":"Siboni","year":"2009","journal-title":"Haemophilia"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2021.07.010_bib44","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1538-7836.2011.04372.x","article-title":"Gynecological and obstetrical manifestations of inherited bleeding disorders in women","volume":"9","author":"Peyvandi","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"10.1016\/j.hoc.2021.07.010_bib45","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/ejh.12767","article-title":"Prevalence of bleeding manifestations in 128 heterozygotes for Factor X deficiency, mainly for FX Friuli, matched versus 128 unaffected family members, during a long sequential observation period (23.5 years)","volume":"97","author":"Girolami","year":"2016","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.hoc.2021.07.010_bib46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.transci.2006.02.004","article-title":"Update on pathogen reduction technology for therapeutic plasma: an overview","volume":"35","author":"Solheim","year":"2006","journal-title":"Transfus Apher Sci"},{"issue":"7","key":"10.1016\/j.hoc.2021.07.010_bib47","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1111\/trf.15322","article-title":"Platelet transfusion as treatment for factor V deficiency in the parturient: a case report","volume":"59","author":"Drzymalski","year":"2019","journal-title":"Transfusion (Paris)"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2021.07.010_bib48","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1365-2516.2001.00100.x","article-title":"Current therapy for rare factor deficiencies","volume":"7","author":"Di Paola","year":"2001","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.hoc.2021.07.010_bib49","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3324\/haematol.2012.074039","article-title":"Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER)","volume":"98","author":"Napolitano","year":"2013","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.hoc.2021.07.010_bib50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/17425255.2016.1237504","article-title":"Plasma-derived human factor X concentrate for on-demand and perioperative treatment in factor X-deficient patients: pharmacology, pharmacokinetics, efficacy, and safety","volume":"13","author":"Shapiro","year":"2017","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.010_bib51","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/hae.12894","article-title":"Pharmacokinetics of a high-purity plasma-derived factor X concentrate in subjects with moderate or severe hereditary factor X deficiency","volume":"22","author":"Austin","year":"2016","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.010_bib52","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/hae.12893","article-title":"Efficacy, safety and pharmacokinetics of a new high-purity factor X concentrate in subjects with hereditary factor X deficiency","volume":"22","author":"Austin","year":"2016","journal-title":"Haemophilia"},{"issue":"5","key":"10.1016\/j.hoc.2021.07.010_bib53","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/hae.12954","article-title":"Experience of a new high-purity factor X concentrate in subjects with hereditary factor X deficiency undergoing surgery","volume":"22","author":"Escobar","year":"2016","journal-title":"Haemophilia"},{"issue":"10","key":"10.1016\/j.hoc.2021.07.010_bib54","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1111\/jth.14985","article-title":"Use of plasma-derived factor X concentrate in neonates and infants with congenital factor X deficiency","volume":"18","author":"Zimowski","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"10.1016\/j.hoc.2021.07.010_bib55","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/hae.13500","article-title":"Prophylactic treatment of bleeding episodes in children <12 years with moderate to severe hereditary factor X deficiency (FXD): Efficacy and safety of a high-purity plasma-derived factor X (pdFX) concentrate","volume":"24","author":"Liesner","year":"2018","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.hoc.2021.07.010_bib56","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2516.2006.01314.x","article-title":"The obstetric and gynaecological management of women with inherited bleeding disorders--review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors' Organization","volume":"12","author":"Lee","year":"2006","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.hoc.2021.07.010_bib57","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2516.2005.01056.x","article-title":"Pregnancy and oral contraceptives in factor V deficiency: a study of 22 patients (five homozygotes and 17 heterozygotes) and review of the literature","volume":"11","author":"Girolami","year":"2005","journal-title":"Haemophilia"},{"issue":"6","key":"10.1016\/j.hoc.2021.07.010_bib58","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/hae.12167","article-title":"Is prophylaxis required for delivery in women with factor VII deficiency?","volume":"19","author":"Baumann Kreuziger","year":"2013","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.hoc.2021.07.010_bib59","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/hae.14086","article-title":"Management of pregnancy in women with factor VII deficiency: A case series","volume":"26","author":"Lee","year":"2020","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.hoc.2021.07.010_bib60","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/hae.13729","article-title":"Congenital Factor X deficiency in women: A systematic review of the literature","volume":"25","author":"Spiliopoulos","year":"2019","journal-title":"Haemophilia"},{"issue":"5","key":"10.1016\/j.hoc.2021.07.010_bib61","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/jth.13983","article-title":"Efficacy, safety and pharmacokinetics of a new high-purity factor X concentrate in women and girls with hereditary factor X deficiency","volume":"16","author":"Kulkarni","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"issue":"3","key":"10.1016\/j.hoc.2021.07.010_bib62","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1111\/j.1365-2516.2011.02724.x","article-title":"Factor X deficiency and pregnancy: preconception counselling and therapeutic options","volume":"18","author":"Nance","year":"2012","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.hoc.2021.07.010_bib63","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/hae.13465","article-title":"\u201cIn\u00a0vitro\u201d correction of the severe factor V deficiency-related coagulopathy by a novel plasma-derived factor V concentrate","volume":"24","author":"Bulato","year":"2018","journal-title":"Haemophilia"},{"issue":"5","key":"10.1016\/j.hoc.2021.07.010_bib64","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1182\/blood-2015-09-671420","article-title":"Sustained correction of FVII deficiency in dogs using AAV-mediated expression of zymogen FVII","volume":"127","author":"Marcos-Contreras","year":"2016","journal-title":"Blood"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858821000897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858821000897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:17:17Z","timestamp":1760185037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858821000897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0889858821000897"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2021.07.010","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rare Coagulation Factor Deficiencies (Factors VII, X, V, and II)","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2021.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}